Related Experiment Videos
Intracoronary Stent Used in a Transplanted Heart
1Department of Internal Medicine, Division of Cardiology, Auenbruggerplatz 15, A - 8036, Graz, Austria.
Insights
Cardiac allograft vasculopathy, distinct from native coronary artery disease, presents treatment challenges. This case details successful stenting in a heart transplant recipient with significant coronary artery disease.
Area of Science:
- Cardiology
- Transplantation Immunology
- Interventional Cardiology
Background:
- Cardiac allograft vasculopathy (CAV) is a unique form of coronary artery disease following heart transplantation.
- CAV pathogenesis and optimal treatment strategies remain incompletely understood.
- Early detection and intervention are crucial for long-term graft survival.
Purpose of the Study:
- To report a case of significant coronary artery disease in a heart transplant recipient.
- To illustrate the successful application of coronary angioplasty and stenting for CAV.
- To highlight the role of advanced imaging in assessing stent patency.
Main Methods:
- A 53-year-old male heart transplant recipient presented with symptoms of myocardial ischemia.
- Coronary angiography revealed significant two-vessel coronary artery disease.
- Percutaneous coronary intervention with Palmaz-Schatz stent implantation was performed in the left anterior descending artery.
- Ultrafast computed tomography and follow-up angiography were used to assess stent patency.
Main Results:
- Successful coronary angioplasty and stenting of the left anterior descending artery were achieved.
- The implanted Palmaz-Schatz stent remained patent at three-month follow-up.
- Ultrafast computed tomography provided effective visualization of stent patency.
Conclusions:
- Coronary artery disease in heart transplant recipients can be effectively managed with interventional techniques.
- Stenting, specifically with Palmaz-Schatz stents, offers a viable treatment option for significant CAV.
- Multimodality imaging plays a key role in monitoring treatment success in CAV patients.
Abstract:
The development of occlusive cardiac allograft vasculopathy is different from coronary artery disease in native vessels and treatment is still an unsettled problem. We describe a case of a 53-year-old male who underwent heart transplantation because of severe dilated cardiomyopathy. Based on myocardial ischemia, coronary angiography was performed six years later. Significant two-vessel coronary artery disease had developed and was treated by coronary angioplasty. Due to a suboptimal result, a Palmaz-Schatz stent was successfully implanted in the left anterior descending artery. The patency of the stent was demonstrated by ultrafast computed tomography and confirmed by control angiography three months later.